Company profile
Flinn.ai
AI platform for MedTech regulatory and quality process automation.
- Category
- Vertical SaaS
- Headquarters
- Vienna
- Sells to
- Enterprise
- Business model
- SaaS subscription
- Deployment
- Cloud / SaaS
- Pricing
- Not published
- Builds own models
- Yes
- Modalities
- Text
What Flinn.ai does
Flinn.ai is an AI-driven platform designed to automate regulatory and quality processes specifically for the MedTech industry. It helps medical companies launch and operate products more efficiently by handling compliance for low to high-risk medical devices and managing portfolios of any size. The platform ensures full compliance with regulations like FDA, EU MDR, and IVDR, offering solutions for Post-Market Surveillance Reporting (PMS/PSUR), Post-Market Clinical/Performance Follow-Up (PMCF/PMPF), and Clinical Evaluation/Performance Reports (CER/CPR). Flinn.ai provides features for monitoring multiple databases, AI-assisted evaluations, and audit-ready reports, aiming to increase efficiency and reduce internal costs for MedTech companies. The company emphasizes its commitment to accuracy in safety-critical, regulated environments, using carefully validated features, benchmarking state-of-the-art LLMs, and training models on real-world medical data. Flinn.ai also offers a practical, risk-based validation framework called FLARE for AI in regulatory affairs.
Products
- Safety DB MonitoringAutomates global safety database monitoring for comprehensive compliance and time-saving. It provides access to over 15 safety databases, real-time monitoring, 1-click audit-readiness, automated de-duplication, and accessible market insights.
- Literature EvaluationAccelerates literature research for MedTech compliance. It allows searching over 40 million papers, offers AI screening support to flag non-human studies, enables purchasing restricted-access literature, provides agentic data extraction from full-text papers, and ensures comprehensive checks with AI Audit Assurance.
- Regulatory MonitoringMonitors normative documents and regulatory changes. It provides AI-assisted impact assessment of changes, screens changes with detailed gap analysis, offers suggestions on relevancy for medical device manufacturers, covers international and national regulations, guidelines, and standards, and monitors guidance documents from IMDRF, GHTF, MEDDEV, and MDCG.
- Complaint HandlingA solution for managing complaints within the MedTech regulatory framework.
Key capabilities
- AI-driven platform to automate regulatory and quality processes
- Built for MedTech compliance complexity
- Handles low to high-risk medical devices
- Manages portfolios of any size (SMEs to enterprises)
- Ensures full compliance with FDA, EU MDR, IVDR, and other global requirements
- Monitor smarter: Search multiple databases at once
- Faster evaluations: AI-assisted
- Audit-ready reports: With one click
- Increased efficiency: Reduce internal costs
- 15+ Databases Accessible with 1-Click (for Safety DB Monitoring)
- Real-time Monitoring (for Safety DB Monitoring)
- Automated De-Duplication (for Safety DB Monitoring)
- Easily Accessible Market Insights (for Safety DB Monitoring)
- 40+ million papers search (for Literature Evaluation)
- AI Screening Support (for Literature Evaluation)
- Purchase relevant literature (for Literature Evaluation)
- Agentic Data Extraction (for Literature Evaluation)
- AI Audit Assurance (for Literature Evaluation)
- AI Agent Impact Assessment of Regulatory Changes (for Regulatory Monitoring)
- Full coverage of International and national Regulations, Guidelines, and Standards (for Regulatory Monitoring)
- Complete Monitoring of Guidance Documents (for Regulatory Monitoring)
- Broad List of Details (for Regulatory Monitoring)
- Recommendation of New Elements (for Regulatory Monitoring)
- Validated Software and Documentation (adheres to IEC 62304, ISO/TR 80002-2, ISO 13485)
- Reliable and Certified Systems (ISO 27001, ISO 14971, FDA 21 CFR Part 11 compliant)
- Top-class AI accuracy rates
- AI and non-AI features tailored exclusively for MedTech industry
- Global AI governance standards compliant (including EU AI Act)
- FLARE: Framework for Levelled AI Risk Evaluation
- Assisted AI, never autonomous (Human-in-the-loop)
- Full explainability of AI recommendations
- Zero data spillover for AI
- No training on customer data for AI models
- AWS Frankfurt hosting (EU only)
- End-to-end encryption of data (in transit and at rest)
- Enhanced login security
- Role-based access controls
- Multi-factor authentication
- Automated database backups and snapshots
- Disaster recovery plan
Use cases
- Automating regulatory and quality processes
- Handling MedTech compliance for medical devices
- Managing portfolios of medical devices
- Ensuring compliance with FDA, EU MDR, IVDR, and other global requirements
- Post-Market Surveillance Reporting (PMS/PSUR)
- Post-Market Clinical/Performance Follow-Up (PMCF/PMPF)
- Clinical Evaluation/Performance Reports (CER/CPR)
- Global safety database monitoring
- Literature evaluation and research
- Regulatory monitoring and change assessment
- Complaint handling
- Streamlining literature reviews and regulatory tracking
- Generating audit-ready reports
- Validating software for MedTech compliance
AI approach
Flinn.ai is an AI-driven platform that automates regulatory and quality processes for MedTech compliance. It uses AI for tasks like safety database monitoring, literature evaluation, and regulatory monitoring. The company emphasizes its commitment to accuracy in safety-critical, regulated environments, validating features, benchmarking models for each task, and training on real-world medical data. New AI features are launched in isolated environments, reviewed by experts, tested with real users, and integrated into live workflows only when proven effective and trustworthy. Flinn.ai benchmarks state-of-the-art LLMs (e.g., OpenAI, Claude, and LLaMA) to select the best model for each use case. Performance is continuously monitored and models are updated. Their models are trained and validated on curated datasets built with medical experts, using real data from medical devices. Flinn.ai operates with a "human-in-the-loop" approach, where AI-generated outputs are reviewed and approved by qualified users, and no customer data is used for model training.
Tech named: LLMs, OpenAI, Claude, LLaMA
Industries served
- MedTech
- Medical Devices
- IVD (In Vitro Diagnostics)
What it says sets it apart
- AI-driven platform specifically built for MedTech compliance complexity
- Comprehensive coverage of regulatory requirements (FDA, EU MDR, IVDR, etc.)
- Validated software and documentation adhering to industry standards (IEC 62304, ISO/TR 80002-2, ISO 13485)
- Certified systems with high uptime and compliance (ISO 27001, ISO 14971, FDA 21 CFR Part 11)
- Top-class AI accuracy rates, with models trained on real-world medical data
- FLARE framework for practical, risk-based AI validation in regulatory affairs
- Assisted AI approach with human-in-the-loop, full explainability, and no customer data used for model training
- Security architecture with AWS Frankfurt hosting, end-to-end encryption, and robust access controls
- Ability to search 15+ safety databases and over 40 million publications
- Significant time savings in vigilance processes (80% faster) and literature reviews (56% faster)
- Customer-centric, experimentation-driven product development approach
- Expert team with diverse backgrounds from medtech manufacturers, regulated industries, and tech giants
Funding rounds we track
HV Capital, Bertelsmann Healthcare Investments, Cherry Ventures, Speedinvest, SquareOne
From the AI funding tracker — rounds as reported by the linked publications.
This profile was compiled from Flinn.ai's own public pages in July 2026 and reflects what the company states about itself — not an endorsement or an independent audit of those claims. Facts are extracted with AI and filtered by an automated check that drops any named product, customer or certification missing from the source pages. Full method. Something out of date? Tell us.